EUDA Health Holdings (EUDA) Research & Development (2022)

EUDA Health Holdings (EUDA) reported Research & Development of $7195.0 for Q2 2022, up 144.23% quarter-over-quarter from $2946.0 in Q1 2022.

EUDA Health Holdings (EUDA) Research & Development (2022) Analysis & Trends

EUDA Health Holdings (EUDA) has 1 years of Research & Development data on file, last reported at $7195.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 IHS Holding 44.35 Bn 43.37 Bn 231.80 -
2 Cbre 38.64 Bn 37.43 Bn 1.85 Bn -
3 Jones Lang Lasalle 13.86 Bn 13.54 Bn - -
4 Costar 12.44 Bn 11.16 Bn 701.00 Mn 114.00 Mn
5 Compass 7.37 Bn 6.89 Bn 2.31 Bn 119.00 Mn
6 KE Holdings 7.04 Bn 4.80 Bn 661.06 Mn -71.41 Mn
7 Opendoor Technologies 4.28 Bn 4.21 Bn 72.00 Mn 24.00 Mn
8 Cushman & Wakefield 3.00 Bn 2.40 Bn 420.70 Mn -
9 Newmark 2.71 Bn 2.66 Bn - -
10 EUDA Health Holdings - - - -

Historic Data

Download Data
DateValue
Jun 30, 2022 7,195.00
Mar 31, 2022 2,946.00